(PharmaNewsWire.Com, March 06, 2017 ) Rise in new diseases and growing demand for therapeutics in various diseases are the factors driving the market growth. Stringent regulations and high initial cost associated with drug discovery are the factors hampering the market. Discovering drugs for diseases like Parkinson disease, cancer, nervous disorders is the opportunity for the market growth.
Applications Covered: - Parkinson’s disease - Cancer - Central Nervous System Disorders - Cardiovascular Diseases - Other Applications
End Users Covered: - Biopharmaceutical Companies - Research Institutes - Biotech Companies - Pharmaceutical Companies
Regions Covered: - North America US Canada Mexico - Europe Germany France Italy UK Spain Rest of Europe - Asia Pacific Japan China India Australia New Zealand Rest of Asia Pacific - Rest of the World Middle East Brazil Argentina South Africa Egypt
1 Executive Summary 3 Market Trend Analysis 4 Porters Five Force Analysis 5 Global Drug Discovery Technologies Market, By Technology 6 Global Drug Discovery Technologies Market, By Application 7 Global Drug Discovery Technologies Market, By End User 8 Global Drug Discovery Technologies Market, By Geography 9 Key Developments 10 Company Profiling 10.1 Bayer Healthcare AG 10.2 Roche Holding AG 10.3 Boehringer Ingelheim GmbH 10.4 Illumina Inc. 10.5 Millennium Pharmaceuticals, Inc. 10.6 Abbott Laboratories 10.7 Beckman Coulter Inc. 10.8 Aviva Biosciences Corp. 10.9 Bio-Rad Laboratories, Inc. 10.10 Novartis AG 10.11 Charles River Laboratories International, Inc. 10.12 Evotec AG 10.13 Merck & Co., Inc. 10.14 Viva Biotech Ltd 10.15 Sri Biosciences 10.16 GE Healthcare Ltd. 10.17 Qiagen N.V. 10.18 Quantum Pharmaceuticals
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: